Patent №
US 7,897,356
Granted
2011-03-01
Filed 2009
Owner
CARIS MPI, INC.
+2 more
Lab
—
AI components
1
planning
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12591226
Exosomes can be used for detecting biomarkers for diagnostic, therapy-related or prognostic methods to identify phenotypes, such as a condition or disease, for example, the stage or progression of a disease. Cell-of-origin exosomes can be used in profiling of physiological states or determining phenotypes. Biomarkers or markers from cell-of-origin specific exosomes can be used to determine treatment regimens for diseases, conditions, disease stages, and stages of a condition, and can also be used to determine treatment efficacy. Markers from cell-of-origin specific exosomes can also be used to identify conditions of diseases of unknown origin.
AI classification
Ownership
CARIS MPI, INC.
assignment · 245400420
CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS, S.A.R.L.
assignment · 276580837
CARIS LIFE SCIENCES SWITZERLAND HOLDINGS GMBH
namechg · 339830910
Assignors
KLASS, MICHAEL, KUSLICH, CHRISTINE, POSTE, GEORGE
On an employer assignment, the assignors are typically the inventors.